Table 1 Laboratory test indicators of the patient

White blood cell (*10^9/L)

9.9

6.92

12.37

14.07

12.5

3.5–9.5

Red blood cell (*10^12/L)

2.41

1.38

1.64

1.1

2.62

3.80–5.10

Lymphocyte (*10^9/L)

0.66

0.31

0.68

0.28

0.12

1.1–3.2

Lymphocyte (%)

7.2

4.5

5.5

2

1

20.0–50.0

Hemoglobin (g/L)

75

42

50

35

81

115.0-150.0

Platelet (*10^9/L)

96

70

82

111

114

125.0-350.0

Clinical criteria

Neutrophils (*10^9/L)

7.8

6.39

10.91

13.17

12.16

1.8–6.3

Neutrophils (%)

85.3

92.3

88.2

93.6

97.2

40.0–75.0

Total protein (g/L)

47.6

38.4

44.8

48.3

66.0–87.0

Albumin (g/L)

32.8

24.7

30.4

31.7

40.0–55.0

Globulin (g/L)

14.8

13.7

14.4

16.6

20–35

ALT (U/L)

10

9

13

14

7–40

AST (U/L)

20

15

24

20

13–35

LDH (U/L)

300

200

380

371

120–250

Creatinine (µmol/L)

225

260

509

415

45–84

eGFR (ml/min/1.73m^2)

17.9

15.7

6.7

8.5

> 90

KDIGO classification

CKD G4

AKI Stage 1

AKI Stage 2

Urea (mmol/L)

14.1

14.3

24.2

24.7

3.1–8.8

Uric acid (µmol/L)

434

446

517

463

142.8-339.2

Cholesterol (mmol/L)

3.17

2.21

3.06

3.16

< 5.18

Total bilirubin (µmol/L)

8.2

6.6

8.6

10.7

≤ 23

APTT (s)

40.1

45.9

39.5

29.0–42.0

Thrombin time (s)

18.9

19.2

17.9

<21.0

Prothrombin activity (%)

106

90

117

80.0-135.0

Prothrombin time (s)

12.9

13.8

12.4

11.5–14.5

Fibrinogen (g/L)

2.4

1.81

2.17

2.00–4.00

D-D dimer (µg/mL FEU)

2.08

1.96

2.38

< 0.5

FDP (µg/mL)

10

< 5.0

Amylopsin (U/L)

55

15–53

Pancreatic lipase (IU/L)

67.7

13–60

NT-proBNP (pg/mL)

2417

2873

< 738

Troponin I (µg/L)

28.1

≤ 15.6

Complement 3 (g/L)

0.64

0.74

0.8–1.8

Immunology criteria

Complement 4 (g/L)

0.17

0.21

0.1–0.4

Immunology criteria

IgA (g/L)

0.59

0.34

0.7-4.0

IgG (g/L)

1.74

4.11

7.0–16.0

IgM (g/L)

0.25

0.17

0.4–2.3

C-reactive protein (mg/L)

6.19

24.1

0–10.0

IL-10 (pg/ml)

5.9

0.1-5.0

IL-2 (pg/ml)

1.39

0.1–4.1

IL-4 (pg/ml)

1.23

0.1–3.2

IL-6 (pg/ml)

5.3

0.1–2.9

IFN-r (pg/ml)

1.78

0.1–18.0

TNF-α (pg/ml)

1.1

0.1–23

ACA

negative

negative

LAC

negative

negative

GM/G test

negative

negative

Coomb's test

negative

negative

Urine protein

3+

negative

Clinical criteria

ANA

1:320 nucleolar type

negative

Immunology criteria

Anti-dsDNA

negative

negative

Anti-Sm

positive

negative

Immunology criteria

Anti-RO52

positive

negative

Anti-CCP (RU/ml)

< 2.00

0–20

AKA

negative

negative

ASO (IU/ml)

2.75

0-250

RF (IU/ml)

16

0–30

ANCA

negative

negative